[University home]

The University of Manchester Library

Patient perceptions of treatment and illness when prescribed multiple medicines for co-morbid type 2 diabetes

Stack, R J; Bundy, C; Elliott, R A; New, J P; Gibson, J M; Noyce, P R

Diabetes Metab Syndr Obes. 2011;4:127-35.

Access to files

Full-text and supplementary files are not available from Manchester eScholar. Full-text is available externally using the following links:


Illness and treatment perceptions are vital for people self-managing co-morbid conditions with associated cardiovascular disease, such as type 2 diabetes (T2D). However, perceptions of a co-morbid condition and the use of multiple medicines have yet to be researched. This study investigated the illness and treatment perceptions of people with co-morbid T2D. The Brief Illness Perception Questionnaire (repeated for T2D, hypertension, and hyperlipidemia) and the Beliefs about Medicines Questionnaire Specific Concerns Scales (repeated for Oral hypoglycemic agents, anti-hypertensive medicines, and statins) were sent to 480 people managing co-morbid T2D. Data on the number of medicines prescribed were collected from medical records. Significantly different perceptions were found across the illnesses. The strongest effect was for personal control; the greatest control reported for T2D. Illness perceptions of T2D differed significantly from perceptions about hyperlipidemia. Furthermore, illness perceptions of T2D also differed from perceptions of hypertension with the exception of perceptions of illness severity. Hypertension and hyperlipidemia shared similar perceptions about comprehensibility, concerns, personal control, and timeline. Significant differences were found for beliefs about treatment necessity, but no difference was found for treatment concerns. When the number of medicines was taken as a between-subjects factor, only intentional non-adherence, treatment necessity beliefs, and perceptions of illness timeline were accounted for. Co-morbid illness and treatment perceptions are complex, often vary between illnesses, and can be influenced by the number of medicines prescribed. Further research should investigate relationships between co-morbid illness and treatment perception structures and self-management practices.

Bibliographic metadata

Type of resource:
Content type:
Published date:
Journal title:
Start page:
End page:
Digital Object Identifier:
10.2147/DMSO.S17444 dmso-4-127 [pii]
ISI Accession Number:
Related website(s):
  • Related website http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21779144
General notes:
  • Stack, Rebecca J Bundy, Chris Elliott, Rachel A New, John P Gibson, J Martin Noyce, Peter R New Zealand Diabetes, metabolic syndrome and obesity : targets and therapy Diabetes Metab Syndr Obes. 2011;4:127-35. Epub 2011 Apr 11.
Access state:

Institutional metadata

University researcher(s):

Record metadata

Manchester eScholar ID:
Created by:
Gibson, Martin
15th January, 2012, 14:43:54
Last modified by:
Gibson, Martin
Last modified:
1st February, 2013, 19:44:52